IGFBP7 Antibodies

Santa Cruz Biotechnology delivers a wide array of IGFBP7 monoclonal antibodies for research focused on understanding Insulin-like Growth Factor Binding Protein 7. IGFBP7 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Insulin-like Growth Factor Binding Protein 7 plays a crucial role in regulating cell growth, differentiation, and apoptosis by modulating the availability of insulin-like growth factors. IGFBP7 has emerged as a significant focus in cancer research and various disease studies due to its involvement in multiple physiological processes. Understanding IGFBP7 function can provide valuable insights into tumor biology and potential therapeutic targets. Researchers can utilize IGFBP7 monoclonal antibodies to investigate protein expression patterns across different tissue types and cellular conditions. Advanced research techniques supported by IGFBP7 monoclonal antibodies enable detailed analysis of protein localization and interaction networks. The specificity and reliability of IGFBP7 monoclonal antibodies from Santa Cruz Biotechnology help advance scientific understanding of cellular pathways and disease mechanisms.